Crossover Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Crossover Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Crossover Therapy Today - Breaking & Trending Today

First Report of PhALLCON: A Phase 3 Study Comparing Ponatinib vs Imatinib in Newly Diagnosed Ph+ ALL

Published: May 22, 2023

Expert Elias Jabbour, MD, reviews clinical data from the PhALLCON study of ponatinib vs imatinib in patients with Ph+ acute lymphocytic leukemia and considers its clinical implications.

Source: onclive.com

Related Topics:

Elias JabbourFirst ReportComparing PonatinibNewly DiagnosedAcute Lymphocytic LeukemiaCall CancerAll LeukemiaPh PositiveOph AllTyrosine Kinase InhibitorsTki TherapyCombination TherapyBcr AblPonatinib DosePonatinib DosingComplete ResponseSurvival DataAdverse EventsDrug Adverse EventMrd NegativityMrd NegativeDuration Of ResponseCrossover TherapySequencing TherapyEvent Free Survival